日本名古屋大学医学部脑神经外科吉田纯(景山直树教授的助手)开始使用人体内存在着的微量生理活性物质——干扰素作为抗癌药物治疗脑肿瘤。并指出单用干扰素对癌细胞的杀伤力较弱、作用范围有限,而与化疗和放疗并用,其疗效较佳,作用范围较广。作者通过对脑肿病患者,特别是对预后差的恶性 Naotoya University’s Department of Neurosurgery, Yoshiya University, Japan, Yoshida Yoshiharu (Professor Jingshan Naoki’s assistant) began to use the trace physiologically active substance in the human body, interferon, as an anti-cancer drug to treat brain tumors. The authors also pointed out that the use of interferon alone has a weaker lethal effect on cancer cells and has a limited range of effects. Combined with chemotherapy and radiotherapy, it has a better curative effect and a wider range of effects. The authors passed on the patients with encephalopathy, especially the poor prognosis